stella
beta
Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer — Stella
Recruiting
Back to Non-small Cell Lung Cancer Stage IIIC trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
University of California Davis Comprehensive Cancer Center, Sacramento, California
View full record on ClinicalTrials.gov